Since 1979, Boston Scientific has been a global leader in medical technology, providing a broad range of high-performance solutions that address unmet patient needs while reducing healthcare costs. It developed an innovative pVAD (percutaneous ventricular assist device) to support heart function during high-risk interventions to treat coronary disease. In this minimally invasive system, a miniature heart pump accesses the heart through a vessel in the leg. Once positioned, it keeps blood flowing to vital organs. The system’s design reduces set-up time, simplifies workflow, more securely positions the pump, and eliminates the need for a purge line, all of which reduce patient complications and improve health outcomes.
As a long-time client, Boston Scientific turned to Catchword to develop a name for this life-saving technology. Vitalyst instantly conveys the critical need the system meets and the vitality it preserves while recalling the precision and transformation of analyst and catalyst. The company will begin clinical trials for Vitalyst later in 2024.
